Aker BioMarine ASA

09/17/2021 | Press release | Distributed by Public on 09/17/2021 00:00

Organizational change and ramp-up of Kori Krill Oil distribution in the US

Aker BioMarine appoints industry leader Seth French as new CEO for the company's Brands segment. Mr. French will report to CEO in Aker BioMarine, Matts Johansen. 'With his broad experience from the food and beverage industry, his strategic mindset and solid track record, Seth will be an excellent addition to the team. He will play an important part by leading the expansion of Brands in the US market', says Mr. Johansen. Most recently, Mr. French was president in Lassonde Pappas Private Label Division, one of the premier private brand beverage companies in the US. He has held various top positions in Lassonde Pappas for the last 14 years. 'Aker BioMarine is a very exciting company that has proven itself to be an innovative player in the healthy supplements and nutrition market and a leading force in terms of market development. I am excited by the growth opportunities ahead' says Mr. French. As a part of building the brand segment, Aker BioMarine bought Lang Pharma Nutrition in 2019. Lang is a key partner to the world's leading mass market retail chains such as Costco, Sam's Club, Walmart, Target, CVS and Walgreens, and is supplying dietary supplement and nutrition products. The U.S. vitamin and supplement industry is a growing market, and for Aker BioMarine it is especially important to develop and expand the omega-3 category. In 2020, Aker BioMarine established Epion, a consumer brand company delivering Kori Krill Oil in the US market. Today, the brand is available in retail chains in the US, including Costco, CVS, Sam's Club, Target, Wakefern, Walgreens, Walmart and more. One of these retail chains has awarded Epion a significant increase in distribution of Kori from the first quarter of 2022. The impact of the increased distribution is uncertain, but it is nevertheless an important step towards our ambition for the Kori brand. About Aker BioMarine AkerBioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®), aquaculture (QRILL®Aqua), and animal feed applications (QRILL®Pet), including INVI™, a highly concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill. Aker BioMarine's fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company's strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste. For further information go to www.akerbiomarine.com